Request Demo
Last update 19 Apr 2026
Suzhou Stainwei Biotechnology Co., Ltd.
Last update 19 Apr 2026
Overview
Tags
Neoplasms
Endocrinology and Metabolic Disease
Eye Diseases
Monoclonal antibody
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20190495
抗PD-1人源化单抗hAB21注射液治疗晚期恶性实体瘤患者的耐受性、安全性和药代动力学I 期临床研究
[Translation] Phase I clinical study on the tolerability, safety and pharmacokinetics of anti-PD-1 humanized monoclonal antibody hAB21 injection in patients with advanced malignant solid tumors
CTR20181938
抗VEGF单抗苏洛晍SOLOT-Eye 治疗新生血管性年龄相关性黄斑变性（湿性AMD）患者的安全性、耐受性和初步疗效的I期临床试验
[Translation] A phase I clinical trial to evaluate the safety, tolerability and preliminary efficacy of the anti-VEGF monoclonal antibody SOLOT-Eye in the treatment of patients with neovascular age-related macular degeneration (wet AMD)
CTR20160585
人源化hPV19单克隆抗体注射液治疗晚期恶性实体瘤患者的耐受性、安全性和药代动力学 I 期临床研究
[Translation] Phase I clinical study on the tolerability, safety and pharmacokinetics of humanized hPV19 monoclonal antibody injection in the treatment of patients with advanced malignant solid tumors
100 Clinical Results associated with Suzhou Stainwei Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Suzhou Stainwei Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Stainwei Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Apr 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
7
Preclinical
Phase 1
1
2
Phase 2
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free